Latest Insider Transactions at Angiodynamics Inc (ANGO)
This section provides a real-time view of insider transactions for Angiodynamics Inc (ANGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANGIODYNAMICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANGIODYNAMICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 10
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Open market or private purchase
|
Direct |
100
+0.22%
|
$600
$6.08 P/Share
|
|
Oct 08
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Open market or private purchase
|
Direct |
1,700
+0.97%
|
$8,500
$5.86 P/Share
|
|
Oct 07
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Open market or private purchase
|
Direct |
768
+1.65%
|
$4,608
$6.09 P/Share
|
|
Oct 07
2024
|
James C Clemmer President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+2.85%
|
$120,000
$6.03 P/Share
|
|
Jul 21
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.4%
|
$4,669
$7.13 P/Share
|
|
Jul 21
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.67%
|
$1,939
$7.13 P/Share
|
|
Jul 21
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,372
-0.53%
|
$23,604
$7.13 P/Share
|
|
Jul 21
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-1.07%
|
$2,891
$7.13 P/Share
|
|
Jul 21
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.62%
|
$2,765
$7.13 P/Share
|
|
Jul 20
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.43%
|
$5,019
$7.13 P/Share
|
|
Jul 20
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.6%
|
$1,757
$7.13 P/Share
|
|
Jul 20
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,982
-0.47%
|
$20,874
$7.13 P/Share
|
|
Jul 20
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.58%
|
$4,312
$7.13 P/Share
|
|
Jul 20
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.56%
|
$2,513
$7.13 P/Share
|
|
Jul 19
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,585
-1.49%
|
$18,095
$7.18 P/Share
|
|
Jul 19
2024
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,817
+0.59%
|
-
|
|
Jul 19
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.57%
|
$7,175
$7.18 P/Share
|
|
Jul 19
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,307
-1.29%
|
$58,149
$7.18 P/Share
|
|
Jul 19
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.74%
|
$5,145
$7.18 P/Share
|
|
Jul 19
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-4.83%
|
$13,881
$7.18 P/Share
|
|
Jul 17
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
2,485
-5.85%
|
$17,395
$7.4 P/Share
|
|
Jul 17
2024
|
Laura Piccinini SVP International |
BUY
Exercise of conversion of derivative security
|
Direct |
4,439
+9.46%
|
-
|
|
Jul 17
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-3.57%
|
$11,662
$7.4 P/Share
|
|
Jul 17
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
5,677
+10.84%
|
-
|
|
Jul 17
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,730
-4.16%
|
$201,110
$7.4 P/Share
|
|
Jul 17
2024
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,279
+7.54%
|
-
|
|
Jul 17
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,016
-2.26%
|
$28,112
$7.4 P/Share
|
|
Jul 17
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,142
+5.9%
|
-
|
|
Jul 17
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
2,379
-3.39%
|
$16,653
$7.4 P/Share
|
|
Jul 17
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+8.6%
|
-
|
|
Jul 17
2024
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+19.09%
|
-
|
|
Jul 17
2024
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+22.02%
|
-
|
|
Jul 17
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
38,953
+18.84%
|
-
|
|
Jul 17
2024
|
Lorinda Burgess |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+35.34%
|
-
|
|
Jul 17
2024
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+12.09%
|
-
|
|
Jul 17
2024
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,811
+14.1%
|
-
|
|
Jul 17
2024
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+14.03%
|
-
|
|
Jul 17
2024
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+23.82%
|
-
|
|
Jul 17
2024
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+19.04%
|
-
|
|
Jul 17
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
12,350
+15.89%
|
-
|
|
Jul 17
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
18,733
+30.71%
|
-
|
|
Jul 17
2024
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
21,971
+34.86%
|
-
|
|
Apr 08
2024
|
James C Clemmer President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+1.82%
|
$60,000
$6.7 P/Share
|
|
Feb 29
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,927
+1.47%
|
$7,708
$4.67 P/Share
|
|
Jul 21
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.82%
|
$3,160
$8.65 P/Share
|
|
Jul 21
2023
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-2.12%
|
$3,304
$8.65 P/Share
|
|
Jul 21
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
255
-0.44%
|
$2,040
$8.65 P/Share
|
|
Jul 21
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.27%
|
$2,920
$8.65 P/Share
|
|
Jul 21
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,372
-0.63%
|
$26,976
$8.65 P/Share
|
|
Jul 21
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.58%
|
$5,336
$8.65 P/Share
|